Publicado
Intervenciones farmacéuticas de información y educación en una organización de pacientes costarricenses con hemodiálisis desde un centro de información de medicamentos
Pharmaceutical Information and education Interventions in a Costa Rican Hemodialysis Patient Organization from a Drug Information Center
Intervenções de informação e educação farmacêutica em uma organização de pacientes em hemo-diálise da Costa Rica, promovidas por um centro de informação sobre medicamentos
DOI:
https://doi.org/10.15446/rcciquifa.v55n2.126489Palabras clave:
diálisis renal, farmacéutico, servicios de información de medicamentos (es)renal dialysis, pharmacist, drug information services (en)
diálise renal, farmacêutico, serviços de informação sobre medicamentos (pt)
Descargas
Objetivo: Identificar las intervenciones farmacéuticas de información y educación desarrolladas por el Centro Nacional de Información de Medicamentos orientadas a promover el uso racional de medicamentos en pacientes en hemodiálisis pertenecientes a una organización costarricense. Métodos: Se realizó un estudio descriptivo durante el segundo semestre de 2019 y el primer trimestre de 2020. Se incluyeron 37 pacientes mediante muestreo por conveniencia. Las variables sociodemográficas, clínicas y farmacoterapéuticas se recolectaron mediante entrevista estructurada, y la adherencia terapéutica se evaluó utilizando el test de Morisky–Green–Levine. Se aplicaron estadísticas descriptivas y modelos de regresión lineal para analizar la asociación entre el número de medicamentos prescritos y las variables clínicas. Resultados: La edad media de los participantes fue de 42,2 ± 14,2 años, con distribución equitativa por sexo. Los problemas de salud más frecuentes fueron hipertensión arterial (83,8%), alteraciones del metabolismo mineral óseo (81,1%) y anemia (78,4%). La adherencia terapéutica se observó en el 59,5% de los pacientes. El análisis de regresión lineal identificó al número de problemas de salud como el principal predictor del número de medicamentos prescritos. Todas las intervenciones farmacéuticas fueron aceptadas por los pacientes e incluyeron educación sobre el uso de medicamentos y problemas de salud, recomendaciones higiénico-dietéticas, entrega de recursos informativos y elaboración de horarios de medicación. Conclusiones: La falta de adherencia terapéutica constituye un problema relacionado con los medicamentos frecuente en una muestra de pacientes en hemodiálisis. Las intervenciones farmacéuticas centradas en información y educación, desarrolladas por el Centro Nacional de Información de Medicamentos, fueron ampliamente aceptadas y contribuyen a mejorar la seguridad y efectividad del tratamiento, lo que refuerza la relevancia de la integración del farmacéutico en el abordaje multidisciplinario de esta población.
Objective: To identify pharmaceutical information and education interventions developed by the National Drug Information Center aimed at promoting the rational use of medicines among patients undergoing hemodialysis belonging to a Costa Rican patient organization. Methods: A descriptive study was conducted during the second half of 2019 and the first quarter of 2020. A total of 37 patients were included using convenience sampling. Sociodemographic, clinical, and pharmacotherapeutic variables were collected through structured interviews, and medication adherence was assessed using the Morisky–Green–Levine test. Descriptive statistics and linear regression models were applied to analyze the association between the number of prescribed medications and clinical variables. Results: The mean age of participants was 42.2 ± 14.2 years, with an equal sex distribution. The most frequent health conditions were arterial hypertension (83.8%), mineral and bone metabolism disorders (81.1%), and anemia (78.4%). Medication adherence was observed in 59.5% of patients. Linear regression analysis identified the number of health conditions as the main predictor of the number of prescribed medications. All pharmaceutical interventions were accepted by patients and included education on medication use and health conditions, hygienic–dietary recommendations, provision of informational resources, and development of medication schedules. Conclusions: Lack of medication adherence represents a frequent drug-related problem among patients undergoing hemodialysis. Pharmaceutical interventions focused on information and education, developed by the National Drug Information Center, were widely accepted and contribute to improving treatment safety and effectiveness, reinforcing the importance of integrating pharmacists into a multidisciplinary approach to patient care.
Objetivo: Identificar as intervenções de informação e educação farmacêutica desenvolvidas pelo Centro Nacional de Informação sobre Medicamentos com o objetivo de promover o uso racional de medicamentos em pacientes em hemodiálise pertencentes a uma organização da Costa Rica. Métodos:Foi realizado um estudo descritivo durante o segundo semestre de 2019 e o primeiro trimestre de 2020. Trinta e sete pacientes foram incluídos por amostragem de conveniência. Variáveis sociodemográficas, clínicas e farmacoterapêuticas foram coletadas por meio de entrevistas estruturadas, e a adesão terapêutica foi avaliada pelo teste de Morisky-Green-Levine. Estatísticas descritivas e modelos de regressão linear foram aplicados para analisar a associação entre o número de medicamentos prescritos e as variáveis clínicas. Resultados: A idade média dos participantes foi de 42,2 ± 14,2 anos, com distribuição igual entre os sexos. Os problemas de saúde mais frequentes foram hipertensão (83,8%), distúrbios do metabolismo mineral ósseo (81,1%) e anemia (78,4%). A adesão terapêutica foi observada em 59,5% dos pacientes. A análise de regressão linear identificou o número de problemas de saúde como o principal preditor do número de medicamentos prescritos. Todas as intervenções farmacêuticas foram aceitas pelos pacientes e incluíram educação sobre o uso de medicamentos e problemas de saúde, recomendações de higiene e dieta, fornecimento de recursos informativos e elaboração de um esquema de medicação. Conclusões: A falta de adesão terapêutica é um problema frequente relacionado à medicação em uma amostra de pacientes em hemodiálise. As intervenções farmacêuticas focadas em informação e educação, desenvolvidas pelo Centro Nacional de Informação sobre Medicamentos, foram amplamente aceitas e contribuem para melhorar a segurança e a eficácia do tratamento, reforçando a importância da integração do farmacêutico na abordagem multidisciplinar a essa população.
Referencias
1. J.C. Lv & L.X. Zhang. Prevalence and disease burden of chronic kidney disease. In: B.C. Liu, H.Y. Lan & L.L. Lv (editors). Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, vol 1165. Springer, Singapore, 2019; pp. 3–15. https://doi.org/10.1007/978-981-13-8871-2_1
2. T. Mesbahi, S. Barbouch, M. Najjar, S. Fattoum, H. Jebali, R. Trabelsi, et al. End-stage renal disease at dialysis initiation: Epidemiology and mortality risks during the first year of hemodialysis. Saudi Journal of Kidney Diseases and Transplantation, 32(5), 1407–1417 (2021). https://doi.org/10.4103/1319-2442.344761
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314 (2024). https://doi.org/10.1016/j.kint.2023.10.018
4. A.K. Bello, I.G. Okpechi, M.A. Osman, Y. Cho, H. Htay, V. Jha, M. Wainstein & D.W. Johnson. Epidemiology of haemodialysis outcomes. Nature Reviews Nephrology, 18(6), 378–395 (2022). https://doi.org/10.1038/s41581-022-00542-7
5. H. Htay, A.K. Bello, A. Levin, M. Lunney, M.A. Osman, F. Ye, et al. Hemodialysis use and practice patterns: An international survey study. American Journal of Kidney Diseases, 77(3), 326–335.e1 (2021). https://doi.org/10.1053/j.ajkd.2020.05.030
6. A. Pereira-Céspedes, A. Jiménez-Morales, A. Polo-Moyano, M. Palomares-Bayo, F. Martínez-Martínez & M.Á. Calleja-Hernández. Factors contributing to negative outcomes associated with medications and drug-related problems in kidney replacement therapy-a hospital-based prospective observational study. Journal of Clinical Medicine, 13(4), 1048 (2024). https://doi.org/10.3390/jcm13041048
7. A. Pereira-Céspedes, A. Jiménez-Morales, M. Palomares-Bayo, F. Martínez-Martínez & M.Á. Calleja-Hernández. Medication review with follow-up for end-stage renal disease: Drug-related problems and negative outcomes associated with medication-A systematic review. Journal of Clinical Medicine, 12(15), 5080 (2023). https://doi.org/10.3390/jcm12155080
8. K.C.M. Win, H. Zhou, V. Patton, M. Steen & P. Della. Factors contributing to non-adherence to treatment among adult patients with long-term haemodialysis: An integrative review. Nursing Reports, 15(9), 314 (2025). https://doi.org/10.3390/nursrep15090314
9. M. Alshamrani, A. Almalki, M. Qureshi, O. Yusuf & S. Ismail. Polypharmacy and medication-related problems in hemodialysis patients: A call for deprescribing. Pharmacy, 6(3), 76 (2018). https://doi.org/10.3390/pharmacy6030076
10. T.M. Salgado, R. Moles, S.I. Benrimoj & F. Fernandez-Llimos. Pharmacists’ interventions in the management of patients with chronic kidney disease: A systematic review. Nephrology Dialysis Transplantation, 27(1), 276–292 (2012). https://doi.org/10.1093/ndt/gfr287
11. O.Y. Alshogran, M.H. Hajjar, S.M. Muflih & K.H. Alzoubi. The role of clinical pharmacist in enhancing hemodialysis patients' adherence and clinical outcomes: a randomized-controlled study. International Journal of Clinical Pharmacy, 44(5), 1169–1178 (2022). https://doi.org/10.1007/s11096-022-01453-0
12. C. Daifi, B. Feldpausch, P.-A. Roa & J. Yee. Implementation of a clinical pharmacist in a hemodialysis facility: A quality improvement report. Kidney Medicine, 3(2), 241–247.e1 (2021) doi: https://doi.org/10.1016/j.xkme.2020.11.015
13. N.M. Susilawati, E. Halimah & S. Saidah. Pharmacists’ strategies to detect, resolve, and prevent DRPs in CKD patients. Pharmacia, 68(3), 619–626 (2021). https://doi.org/10.3897/pharmacia.68.e65136
14. G.S. Paneerselvam, C. Kah Yee C, M.J. Farrukh, A. Yuda, A. Hermansyah, M.F. Mohd Asmani MF, I. Abdullah & L.C. Ming. Impact of pharmacist-led medication review among hemodialysis patients: a systematic review. Journal of Pharmaceutical Policy and Practice, 18(1), 2446912 (2025). https://doi.org/10.1080/20523211.2024.2446912
15. I.J. Oosting, J.M.T. Colombijn, L. Kaasenbrood, S. Liabeuf, S.M. Laville, L. Hooft, M.L. Bots, M.C. Verhaar & R.W.M. Vernooij. Polypharmacy in patients with CKD: A systematic review and meta-analysis. Kidney360, 5(6), 841–850 (2024). https://doi.org/10.34067/kid.0000000000000447
16. A. Intilangelo, S. Majic, V. Palchik & M.L. Traverso. Validated questionnaires on medication adherence and associated factors in chronic patients: A systematic review. Farmacia Hospitalaria, 48(4), T185–T192 (2024). https://doi.org/10.1016/j.farma.2024.04.019
17. H.J. Manley, M.L. McClaran, D.K. Overbay, M.A. Wright, G.M. Reid, W.L. Bender, T.K. Neufeld, S. Hebbar & R.S. Muther. Factors associated with medication-related problems in ambulatory hemodialysis patients. American Journal of Kidney Diseases, 41(2), 386–393 (2003). https://doi.org/10.1053/ajkd.2003.50048
18. W.S. Alruqayb, M.J. Price, V. Paudyal & A.R. Cox. Drug-related problems in hospitalised patients with chronic kidney disease: A systematic review. Drug Safety, 44(10), 1041–1058 (2021). https://doi.org/10.1007/s40264-021-01099-3
19. N. Lameire & W. Van Biesen. The initiation of renal-replacement therapy--just-in-time delivery. The New England Journal of Medicine, 363(7), 678–680 (2010) doi: https://doi.org/10.1056/nejme1006669
20. K.M. Murali & M. Lonergan. Breaking the adherence barriers: Strategies to improve treatment adherence in dialysis patients. Seminars in Dialysis, 33(6), 475-485 (2020). https://doi.org/10.1111/sdi.12925
21. B. Sultan & E.S. Froelicher. Effectiveness of patient education on adherence to treatment regimen and quality of life in hemodialysis patients: a systematic review and meta-analysis. Minerva Urology and Nephrology, 77(6), 762–775 (2025). https://doi.org/10.23736/S2724-6051.24.05718-5
22. A.J. Kim, H. Lee, E.-J. Shin, E.-J. Cho, Y.-S. Cho, H. Lee & J.-Y. Lee. Pharmacist-led collaborative medication management for the elderly with chronic kidney disease and polypharmacy. International Journal of Environmental Research and Public Health, 18(8), 4370 (2021). https://doi.org/10.3390/ijerph18084370
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2026 Revista Colombiana de Ciencias Químico-Farmacéuticas

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
El Departamento de Farmacia de la Facultad de Ciencias de la Universidad Nacional de Colombia autoriza la fotocopia de artículos y textos para fines de uso académico o interno de las instituciones citando la fuente. Las ideas emitidas por los autores son responsabilidad expresa de estos y no de la revista.
Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons de Atribución 4.0 aprobada en Colombia. Consulte la normativa en: http://co.creativecommons.org/?page_id=13




